Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738541017 | Benzoyl peroxide and clindamycin only product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3738542012 | Product containing only benzoyl peroxide and clindamycin in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Benzoyl peroxide and clindamycin only product in cutaneous dose form | Has active ingredient | Clindamycin (substance) | true | Inferred relationship | Some | 1 | |
| Benzoyl peroxide and clindamycin only product in cutaneous dose form | Is a | Product containing only benzoyl peroxide and clindamycin (medicinal product) | true | Inferred relationship | Some | ||
| Benzoyl peroxide and clindamycin only product in cutaneous dose form | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Benzoyl peroxide and clindamycin only product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Benzoyl peroxide and clindamycin only product in cutaneous dose form | Has active ingredient | Benzoyl peroxide | true | Inferred relationship | Some | 2 | |
| Benzoyl peroxide and clindamycin only product in cutaneous dose form | Is a | Benzoyl peroxide- and clindamycin-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Benzoyl peroxide and clindamycin only product in cutaneous dose form | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | True | Benzoyl peroxide and clindamycin only product in cutaneous dose form | Inferred relationship | Some | |
| Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | True | Benzoyl peroxide and clindamycin only product in cutaneous dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR